Education
About Us
Working with TipRanks
Follow Us
Sunho Biologics,Inc. (HK:2898)
:2898
2898 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$3.00 - HK$8.60
Previous CloseN/A
Volume4.80K
Average Volume (3M)14.44K
Market Cap
N/A
Enterprise ValueHK$370.01M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding156,666,800
10 Day Avg. Volume18,340
30 Day Avg. Volume14,440
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sunho Biologics,Inc. News
2898 FAQ
What was Sunho Biologics,Inc.’s price range in the past 12 months?
Sunho Biologics,Inc. lowest stock price was HK$3.00 and its highest was HK$8.60 in the past 12 months.
What is Sunho Biologics,Inc.’s market cap?
Currently, no data Available
When is Sunho Biologics,Inc.’s upcoming earnings report date?
Sunho Biologics,Inc.’s upcoming earnings report date is Aug 29, 2025 which is 26 days ago.
How were Sunho Biologics,Inc.’s earnings last quarter?
Sunho Biologics,Inc. released its earnings results on Mar 31, 2025. The company reported -HK$0.316 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.316.
Is Sunho Biologics,Inc. overvalued?
According to Wall Street analysts Sunho Biologics,Inc.’s price is currently Overvalued.
Does Sunho Biologics,Inc. pay dividends?
Sunho Biologics,Inc. does not currently pay dividends.
What is Sunho Biologics,Inc.’s EPS estimate?
Sunho Biologics,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sunho Biologics,Inc. have?
Sunho Biologics,Inc. has 156,666,800 shares outstanding.
What happened to Sunho Biologics,Inc.’s price movement after its last earnings report?
Sunho Biologics,Inc. reported an EPS of -HK$0.316 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.054%.
Which hedge fund is a major shareholder of Sunho Biologics,Inc.?
Currently, no hedge funds are holding shares in HK:2898
Company Description
Sunho Biologics,Inc.
Sunho Biologics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems. It offers IAH0968, an antibody-dependent cell mediated cytotoxicity enhanced monoclonal antibody, which is in the Phase II clinical trials for biliary tract carcinoma and colorectal cancer (CRC). The company also provides IAP0971 and IAE0972 immunocytokines, which have completed Phase I clinical trials for advanced solid tumors, including non-small cell lung cancer and CRC. In addition, its preclinical stage products include IBB0979, an immunocytokine for solid tumors; IBC0966, a clinical stage anti-PD-L1 antibody-signal regulatory protein bifunctional fusion protein for tumor specific immune responses; IBD0333 for tumor cells; IAN0982 for oncology; and ISH0988 and ISH0613 immunosuppressors focused on autoimmune diseases. The company was founded in 2018 and is headquartered in Huzhou, China. Sunho Biologics, Inc. is a subsidiary of Sunho Wisdom Investments Limited.